Market Research Logo

Alzheimer's Disease Pipeline Highlights – 2017 Update

Alzheimer's Disease Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Alzheimer's Disease Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Alzheimer's Disease market. It covers emerging therapies for Alzheimer's Disease in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Alzheimer's Disease pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Alzheimer's Disease pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Alzheimer's Disease pipeline products by the company.

Short-term Launch Highlights:
Find out which Alzheimer's Disease pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

  • Alzheimer's Disease phase 3 clinical trial pipeline products
  • Alzheimer's Disease phase 2 clinical trial pipeline products
  • Alzheimer's Disease phase 1 clinical trial pipeline products
  • Alzheimer's Disease preclinical research pipeline products
  • Alzheimer's Disease discovery stage pipeline products
  • Alzheimer's Disease pipeline products short-term launch highlights


1. Alzheimer's Disease Pipeline by Stages
2. Alzheimer's Disease Pipeline by Drug Class
3. Alzheimer's Disease Pipeline by Company
4. Alzheimer's Disease Phase 3 Clinical Trial Insights
5. Alzheimer's Disease Phase 2 Clinical Trial Insights
6. Alzheimer's Disease Phase 1 Clinical Trial Insights
7. Alzheimer's Disease Preclinical Research Insights
8. Alzheimer's Disease Discovery Stage Insights
9. Appendix
10. Research Methodology
LIST OF TABLES
Table 1: Alzheimer's Disease Phase 3 Clinical Trials, 2017
Table 2: Alzheimer's Disease Phase 2 Clinical Trials, 2017
Table 3: Alzheimer's Disease Phase 1 Clinical Trials, 2017
Table 4: Alzheimer's Disease Preclinical Research, 2017
Table 5: Alzheimer's Disease Discovery Stage, 2017
LIST OF FIGURES
Figure 1: Alzheimer's Disease Pipeline Molecules by Clinical Trials Stage, 2017
Figure 2: Alzheimer's Disease Pipeline Molecules by Drug Class, 2017
Figure 3: Alzheimer's Disease Pipeline Molecules by Company, 2017
Figure 4: Alzheimer's Disease Phase 3 Clinical Trial Highlights, 2017
Figure 5: Alzheimer's Disease Phase 2 Clinical Trial Highlights, 2017
Figure 6: Alzheimer's Disease Phase 1 Clinical Trial Highlights, 2017
Figure 7: Alzheimer's Disease Preclinical Research Highlights, 2017
Figure 8: Alzheimer's Disease Discovery Stage Highlights, 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report